Viewing Study NCT02817750


Ignite Creation Date: 2025-12-24 @ 5:10 PM
Ignite Modification Date: 2026-02-17 @ 4:44 PM
Study NCT ID: NCT02817750
Status: COMPLETED
Last Update Posted: 2018-06-11
First Post: 2016-06-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pharmacokinetics Study of Zolpidem Hemitartarate Orodispersible Tablet 3.5 mg Formulation
Sponsor: Biolab Sanus Farmaceutica
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None volunteers View
None Pharmacokinetics View